391P Real-world evidence of trastuzumab and pertuzumab with taxanes or vinorelbine as a first-line treatment for HER2-positive metastatic breast cancer
Rosa García, A. Torres Zurita, Fernando Henao, Ruben De Toro Salas et autres
es (code pays fourni par la source)